As with all medications in the GLP-1 receptor agonist class, retatrutide is associated with a range of gastrointestinal side effects , which were the most commonly reported adverse events in Phase 2 trials
10.1073/pnas.1204455109 154 LeibowitzS
Subhani M, Dhanda A, King JA, Warren FC, Creanor S, Davies MJ, Eldeghaidy S, Bawden S, Gowland PA, Bataller R, Greenwood J, Kaar S, Bhala N, Aithal GP (2024) Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review
If metformin-associated lactic acidosis is suspected, immediately discontinue JANUMET XR and institute general supportive measures in a hospital setting
Clinical Monitoring Protocols Establishing a Bassline Assessment : Physicians recommend establishing baseline ophthalmologic assessments before initiating Mounjaro therapy
Injectable forms (Ozempic, Wegovy): These are the semaglutide medications that were tested in the existing research and show no drug transfer to breast milk
